Aemetis, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US00770K2024
USD
1.63
0.04 (2.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

154.59 k

Shareholding (Mar 2025)

FII

3.29%

Held by 31 FIIs

DII

82.92%

Held by 15 DIIs

Promoter

0.00%

How big is Aemetis, Inc.?

22-Jun-2025

As of Jun 18, Aemetis, Inc. has a market capitalization of 125.13 million, with net sales of 237.89 million and a net profit of -87.83 million over the last four quarters. The company reported shareholder's funds of -263.93 million and total assets of 259.30 million as of Dec 24.

Market Cap: As of Jun 18, Aemetis, Inc. has a market capitalization of 125.13 million, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Aemetis, Inc. reported net sales of 237.89 million and a net profit of -87.83 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of -263.93 million and total assets of 259.30 million.

Read More

What does Aemetis, Inc. do?

22-Jun-2025

Aemetis, Inc. is a renewable fuels and biochemicals company with a market cap of $125.13 million, reporting net sales of $43 million and a net loss of $25 million as of March 2025. The company operates in the specialty chemicals industry and has a negative debt equity ratio of -1.65.

Overview: <BR>Aemetis, Inc. is an international renewable fuels and biochemicals company operating in the specialty chemicals industry with a micro-cap market capitalization.<BR><BR>Financial Snapshot: <BR>Net Sales: 43 Million (Quarterly Results - Mar 2025) <BR>Net Profit: -25 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 125.13 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.65 <BR>Return on Equity: 31.29% <BR>Price to Book: -0.45<BR><BR>Contact Details: <BR>Address: 20400 Stevens Creek Blvd Ste 700, CUPERTINO CA : 95014-2296 <BR>Tel: 1 408 5173304 <BR>Fax: 1 408 2528044 <BR>Website: http://www.aemetis.com/

Read More

Who are in the management team of Aemetis, Inc.?

22-Jun-2025

As of March 2022, the management team of Aemetis, Inc. includes Chairman and CEO Eric McAfee, Director Dr. Naomi Boness, and Independent Directors Francis Barton, Lydia Beebe, and John Block.

As of March 2022, the management team of Aemetis, Inc. includes Mr. Eric McAfee, who serves as the Chairman of the Board, Chief Executive Officer, and Co-Founder. Additionally, Dr. Naomi Boness is a Director, while Mr. Francis Barton, Ms. Lydia Beebe, and Mr. John Block serve as Independent Directors.

Read More

Should I buy, sell or hold Aemetis, Inc.?

22-Jun-2025

Is Aemetis, Inc. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, Aemetis, Inc. shows a mildly bearish trend with mixed signals from various indicators and has significantly underperformed the S&P 500, with a year-to-date return of -10.04% compared to the S&P's 12.22%.

As of 10 September 2025, the technical trend for Aemetis, Inc. has changed from sideways to mildly bearish. The weekly MACD and KST indicators are both mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals across time frames. The daily moving averages are mildly bullish, but the overall sentiment is dampened by the weekly and monthly Dow Theory and OBV being mildly bearish. <BR><BR>In terms of performance, Aemetis has underperformed the S&P 500 across multiple periods, with a year-to-date return of -10.04% compared to the S&P 500's 12.22%, and a three-year return of -68.85% versus the S&P 500's 70.41%. Overall, the current technical stance is mildly bearish.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate -248.87% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.60
2

Negative results in Jun 25

3

Risky - Negative EBITDA

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 143 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.63

stock-summary
Return on Equity

28.37%

stock-summary
Price to Book

-0.49

Revenue and Profits:
Net Sales:
52 Million
(Quarterly Results - Jun 2025)
Net Profit:
-23 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-34.54%
0%
-34.54%
6 Months
-6.32%
0%
-6.32%
1 Year
-55.71%
0%
-55.71%
2 Years
-65.32%
0%
-65.32%
3 Years
-70.63%
0%
-70.63%
4 Years
-89.15%
0%
-89.15%
5 Years
-43.5%
0%
-43.5%

Aemetis, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.58%
EBIT Growth (5y)
-248.87%
EBIT to Interest (avg)
-0.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.65
Sales to Capital Employed (avg)
1.24
Tax Ratio
17.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
32.76%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.38
EV to EBIT
-12.28
EV to EBITDA
-15.44
EV to Capital Employed
3.13
EV to Sales
2.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-25.47%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 17 Schemes (13.79%)

Foreign Institutions

Held by 31 Foreign Institutions (3.29%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 21.68% vs -8.72% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 4.49% vs -51.23% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.20",
          "val2": "42.90",
          "chgp": "21.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.20",
          "val2": "-13.00",
          "chgp": "36.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.40",
          "val2": "16.00",
          "chgp": "-10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-23.40",
          "val2": "-24.50",
          "chgp": "4.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-204.30%",
          "val2": "-362.70%",
          "chgp": "15.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 43.33% vs -27.21% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -88.58% vs 56.96% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "267.60",
          "val2": "186.70",
          "chgp": "43.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-31.50",
          "val2": "-30.10",
          "chgp": "-4.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "59.30",
          "val2": "64.80",
          "chgp": "-8.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-87.50",
          "val2": "-46.40",
          "chgp": "-88.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-151.00%",
          "val2": "-200.30%",
          "chgp": "4.93%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
52.20
42.90
21.68%
Operating Profit (PBDIT) excl Other Income
-8.20
-13.00
36.92%
Interest
14.40
16.00
-10.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-23.40
-24.50
4.49%
Operating Profit Margin (Excl OI)
-204.30%
-362.70%
15.84%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 21.68% vs -8.72% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 4.49% vs -51.23% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
267.60
186.70
43.33%
Operating Profit (PBDIT) excl Other Income
-31.50
-30.10
-4.65%
Interest
59.30
64.80
-8.49%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-87.50
-46.40
-88.58%
Operating Profit Margin (Excl OI)
-151.00%
-200.30%
4.93%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 43.33% vs -27.21% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -88.58% vs 56.96% in Dec 2023

stock-summaryCompany CV
About Aemetis, Inc. stock-summary
stock-summary
Aemetis, Inc.
Specialty Chemicals
Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company's approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company's over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.
Company Coordinates stock-summary
Company Details
20400 Stevens Creek Blvd Ste 700 , CUPERTINO CA : 95014-2296
stock-summary
Tel: 1 408 5173304
stock-summary
Registrar Details